,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2022-03-16 16:23:03,2022-03-14,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$7.63,23708,5231504,0%,"+$180,797",,,,,SPRO
1,,2022-03-02 15:52:46,2022-02-28,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$9.53,44833,5207796,+1%,"+$427,227",,,,,SPRO
2,,2022-02-23 16:24:26,2022-02-18,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$9.24,14828,5162963,0%,"+$137,039",,,,,SPRO
3,D,2022-02-03 16:19:47,2022-02-01,SPRO,Melnick David A.,Chief Medical Officer,A - Grant,$0.00,38014,62081,+158%,+$0,,,,,SPRO
4,D,2022-02-03 16:19:40,2022-02-01,SPRO,Shukla Sath,CFO,A - Grant,$0.00,38014,62081,+158%,+$0,,,,,SPRO
5,D,2022-02-03 16:18:28,2022-02-01,SPRO,Larkin Cristina,COO,A - Grant,$0.00,38014,63581,+149%,+$0,,,,,SPRO
6,D,2022-02-03 16:18:13,2022-02-01,SPRO,Mahadevia Ankit,"CEO, Pres",A - Grant,$0.00,134168,278204,+93%,+$0,,,,,SPRO
7,D,2022-02-03 16:18:04,2022-02-01,SPRO,Keutzer Timothy,Chief Development Officer,A - Grant,$0.00,38014,64581,+143%,+$0,,,,,SPRO
8,D,2022-02-03 16:17:12,2022-02-01,SPRO,Joseph Tamara L,GC,A - Grant,$0.00,38014,62081,+158%,+$0,,,,,SPRO
9,,2022-02-01 20:26:17,2022-01-31,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$11.59,125000,5148135,+2%,"+$1,448,263",,,,,SPRO
10,,2022-01-26 17:12:06,2022-01-24,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$10.89,1599,5023135,0%,"+$17,418",,,,,SPRO
11,,2022-01-20 13:07:05,2022-01-18,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$12.41,48488,5021536,+1%,"+$601,964",,,,,SPRO
12,,2022-01-12 16:43:28,2022-01-10,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$12.93,8867,4973048,0%,"+$114,609",,,,,SPRO
13,M,2022-01-03 14:46:29,2021-12-29,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$15.42,250493,4964181,+5%,"+$3,862,898",,,,,SPRO
14,D,2021-12-29 18:26:05,2021-12-27,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,8000,144036,+6%,"+$47,200",,,,,SPRO
15,D,2021-12-29 18:26:05,2021-12-27,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.58,-8000,144036,-5%,"-$116,666",,,,,SPRO
16,,2021-11-02 17:47:57,2021-10-29,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$17.53,150000,4713688,+3%,"+$2,630,175",,,,,SPRO
17,,2021-10-04 11:36:44,2021-09-30,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$18.65,134543,4563688,+3%,"+$2,509,173",,,,,SPRO
18,M,2021-09-15 19:21:42,2021-09-13,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$18.56,46366,4429145,+1%,"+$860,547",,,,,SPRO
19,,2021-09-10 17:21:53,2021-09-09,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$18.50,24749,4382779,+1%,"+$457,792",,,,,SPRO
20,M,2021-09-01 17:42:57,2021-08-30,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$18.42,92687,8667415,+1%,"+$1,707,519",,,,,SPRO
21,,2021-08-30 16:15:48,2021-08-26,SPRO,Melnick David A.,Chief Medical Officer,A - Grant,$0.00,24067,24067,New,+$0,,,,,SPRO
22,,2021-08-30 16:15:43,2021-08-26,SPRO,Mahadevia Ankit,"CEO, Pres",A - Grant,$0.00,78219,144036,+119%,+$0,,,,,SPRO
23,,2021-08-30 16:15:30,2021-08-26,SPRO,Larkin Cristina,COO,A - Grant,$0.00,24067,25567,>999%,+$0,,,,,SPRO
24,,2021-08-30 16:15:23,2021-08-26,SPRO,Joseph Tamara L,GC,A - Grant,$0.00,24067,24067,New,+$0,,,,,SPRO
25,,2021-08-30 16:15:19,2021-08-26,SPRO,Keutzer Timothy,Chief Development Officer,A - Grant,$0.00,24067,26567,+963%,+$0,,,,,SPRO
26,,2021-08-30 16:15:13,2021-08-26,SPRO,Shukla Sath,CFO,A - Grant,$0.00,24067,24067,New,+$0,,,,,SPRO
27,M,2021-08-27 17:11:07,2021-08-26,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$16.67,36939,4265343,+1%,"+$615,854",,,,,SPRO
28,M,2021-08-24 16:28:00,2021-08-20,SPRO,"Aquilo Capital Management, LLC",10%,P - Purchase,$15.51,399195,4228404,+10%,"+$6,192,042",,,,,SPRO
29,,2021-02-10 13:35:13,2021-02-08,SPRO,"Aquilo Capital Management, LLC",10%,S - Sale,$21.74,-3000,3829209,0%,"-$65,215",,,,,SPRO
30,M,2021-02-04 18:46:54,2021-02-01,SPRO,"Aquilo Capital Management, LLC",10%,S - Sale,$19.02,-100000,3832209,-3%,"-$1,901,987",,,,,SPRO
31,M,2020-12-18 16:43:14,2020-12-16,SPRO,"Aquilo Capital Management, LLC",10%,S - Sale,$18.80,-264933,3932209,-6%,"-$4,981,260",,,,,SPRO
32,D,2020-12-18 16:15:08,2020-12-16,SPRO,Larkin Cristina,COO,S - Sale+OE,$19.00,-12000,1500,-89%,"-$228,000",,,,,SPRO
33,D,2020-12-18 16:15:08,2020-12-16,SPRO,Larkin Cristina,COO,M - OptEx,$5.90,12000,1500,-114%,"+$70,800",,,,,SPRO
34,,2020-11-10 19:14:26,2020-11-09,SPRO,"Aquilo Capital Management, LLC",10%,S - Sale,$13.77,-125900,4197142,-3%,"-$1,734,071",,,,,SPRO
35,M,2020-11-06 20:48:12,2020-11-04,SPRO,"Aquilo Capital Management, LLC",10%,S - Sale,$14.09,-174100,4323042,-4%,"-$2,452,948",,,,,SPRO
36,DM,2020-11-05 19:00:10,2020-11-03,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.39,-9507,65817,-13%,"-$136,825",,,,,SPRO
37,DM,2020-11-05 19:00:10,2020-11-03,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,9507,65817,+17%,"+$56,091",,,,,SPRO
38,D,2020-10-27 17:32:27,2020-10-23,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,20,65817,0%,+$118,,,,,SPRO
39,D,2020-10-27 17:32:27,2020-10-23,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.25,-20,65817,0%,-$285,,,,,SPRO
40,DM,2020-10-15 20:24:39,2020-10-13,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.28,-14472,65817,-18%,"-$206,709",,,,,SPRO
41,DM,2020-10-15 20:24:39,2020-10-13,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,14472,65817,+28%,"+$85,385",,,,,SPRO
42,D,2020-09-10 21:51:25,2020-09-08,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.25,-774,65817,-1%,"-$11,030",,,,,SPRO
43,D,2020-09-10 21:51:25,2020-09-08,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,774,65817,+1%,"+$4,567",,,,,SPRO
44,DM,2020-07-09 18:48:00,2020-07-07,SPRO,Mahadevia Ankit,"CEO, Pres",S - Sale+OE,$14.29,-3047,65817,-4%,"-$43,552",,,,,SPRO
45,DM,2020-07-09 18:48:00,2020-07-07,SPRO,Mahadevia Ankit,"CEO, Pres",M - OptEx,$5.90,3047,65817,+5%,"+$17,977",,,,,SPRO
46,,2018-07-17 17:01:46,2018-07-17,SPRO,Glaxosmithkline Plc,10%,P - Purchase,$12.50,80000,1934006,+4%,"+$1,000,000",,,,,SPRO
47,D,2018-07-06 21:45:24,2018-07-05,SPRO,Larkin Cristina,COO,S - Sale+OE,$17.50,-4000,1500,-73%,"-$70,000",,,,,SPRO
48,D,2018-07-06 21:45:24,2018-07-05,SPRO,Larkin Cristina,COO,M - OptEx,$5.90,4000,1500,-160%,"+$23,600",,,,,SPRO
49,D,2018-07-06 21:44:42,2018-07-05,SPRO,Sendek Joel,CFO,S - Sale+OE,$17.50,-2000,15181,-12%,"-$35,000",,,,,SPRO
50,D,2018-07-06 21:44:42,2018-07-05,SPRO,Sendek Joel,CFO,M - OptEx,$5.90,2000,15181,+15%,"+$11,800",,,,,SPRO
51,DM,2018-07-06 21:41:52,2018-07-05,SPRO,Mahadevia Ankit,See Remarks,S - Sale+OE,$17.63,-4676,65817,-7%,"-$82,437",,,,,SPRO
52,DM,2018-07-06 21:41:52,2018-07-05,SPRO,Mahadevia Ankit,See Remarks,M - OptEx,$5.90,4676,65817,+8%,"+$27,588",,,,,SPRO
53,D,2017-11-07 19:42:39,2017-11-06,SPRO,Glaxosmithkline Plc,10%,P - Purchase,$14.00,428571,1854006,+30%,"+$5,999,994",,,,,SPRO
54,D,2017-11-07 19:42:39,2017-11-06,SPRO,Glaxosmithkline Plc,10%,C - Converted deriv,$0.00,1425435,1854006,-43%,$0,,,,,SPRO
55,D,2017-11-07 16:08:53,2017-11-06,SPRO,Formela Jean Francois,Dir,P - Purchase,$14.00,428571,2408128,+22%,"+$5,999,994",,,,,SPRO
56,D,2017-11-07 16:08:53,2017-11-06,SPRO,Formela Jean Francois,Dir,C - Converted deriv,$0.00,1936776,2408128,-45%,$0,,,,,SPRO
57,D,2017-11-07 16:06:22,2017-11-06,SPRO,Goyal Vikas,Dir,P - Purchase,$14.00,428571,1854006,+30%,"+$5,999,994",,,,,SPRO
58,D,2017-11-07 16:06:22,2017-11-06,SPRO,Goyal Vikas,Dir,C - Converted deriv,$0.00,1425435,1854006,-43%,$0,,,,,SPRO
59,D,2017-11-07 16:05:32,2017-11-06,SPRO,Sendek Joel,CFO,P - Purchase,$14.00,5000,25362,+25%,"+$70,000",,,,,SPRO
60,D,2017-11-07 16:05:32,2017-11-06,SPRO,Sendek Joel,CFO,C - Converted deriv,$0.00,10181,25362,-29%,$0,,,,,SPRO
61,,2017-11-07 16:05:30,2017-11-06,SPRO,Larkin Cristina,COO,P - Purchase,$14.00,1500,1500,New,"+$21,000",,,,,SPRO
62,D,2017-11-07 16:05:26,2017-11-06,SPRO,Breum Casper,Dir,C - Converted deriv,$0.00,877489,1091774,-45%,$0,,,,,SPRO
63,D,2017-11-07 16:05:26,2017-11-06,SPRO,Breum Casper,Dir,P - Purchase,$14.00,214285,1091774,+24%,"+$2,999,990",,,,,SPRO
